
解ç±é®çå¤ã®ãããã½ãã³ãã¨ãã«ããã¼ã«ãã£ã¦ä½ãéãã®ï¼ ææ¥éä¸æ²»çå»ãã¤ã©ã¹ãã§è§£èª¬ï¼
åè大å¦çºå»çã¹ã¿ã¼ãã¢ããä¼æ¥ãSmart119ãã¯ãã®ã»ã©ãé®çå¤ã¨ãã¦åºãç¥ããããããã½ãã³ãã¨ãã«ããã¼ã«ãã«ã¤ãã¦ã®ã¤ã©ã¹ãã¬ã¼ã·ã§ã³ãä¸è¬å ¬éãã¾ããã
- é®çå¤ãããã½ãã³ãã¨ãã«ããã¼ã«ãã®éãããã®ãã¤ã³ãã¨ã¯ï¼
- ææ¥éä¸æ²»çå»ã»ä¸ç°åææ°ã«ãããããã½ãã³ã¨ã«ããã¼ã«ã®éãã¨ã¯ï¼ã
- ããã½ãã³ãã«ããã¼ã«ã®éã
- éã¹ããã¤ãæ§æççè¬ã¯ãåã©ããå¦å©¦ã¯é£²ãã§ããã®ï¼
- ã©ããªæã«ããã½ãã³ï¼ã«ããã¼ã«ï¼ 2ã¤ã®ä½¿ãåã

é®çå¤ãããã½ãã³ãã¨ãã«ããã¼ã«ãã®éãããã®ãã¤ã³ãã¨ã¯ï¼
é çãæ¯çãªã©ã®çã¿ãåãããã¾ãçºç±ã®éã«ã¯è§£ç±ä½ç¨ããããããã½ãã³ãã¨ãã«ããã¼ã«ãã¯ãä¸è¬ã®äººã§ã馴æã¿ã®ããè¬ã§ãã
åããããªè¬å¹ããã2種ã§ãããå¯ä½ç¨ãæç¨ã«ã¤ãã¦ã¯å¤§ããªéããããã¾ããã©ã¡ãããã©ãã°ã¹ãã¢ã§æã«å
¥ããããå¸è²©è¬ããããã¨ãããå®å
¨ãªæç¨ã®ããã«ç¥èãå¿
è¦ã§ãã
ä»åãå社ã¯ææ¥éä¸æ²»çå»ã®è¦å°ããããããã½ãã³ãã¨ãã«ããã¼ã«ãã®éããã親ãã¿ããããã³ã¬ã§è§£èª¬ãã¦ãã¾ãããã®è³æã¯å¦æ ¡ãä¼æ¥ãå
Œ
±æ©é¢ãçºå
ä¼çã§èªç±ã«é
å¸ã»å©ç¨ãããã¨ãå¯è½ã§ãã
ææ¥éä¸æ²»çå»ã»ä¸ç°åææ°ã«ãããããã½ãã³ã¨ã«ããã¼ã«ã®éãã¨ã¯ï¼ã
é®çå¤ã解ç±å¤ã¨ãã¦ç¥ããããããã½ãã³ãã¨ãã«ããã¼ã«ãã¯ãå»å¸«ã«ããå¦æ¹ã¯ãã¡ããã®ãã¨ããã©ãã°ã¹ãã¢ãªã©ã§åãæ±ããããå¸è²©è¬ãã¾ãã¸ã§ããªãã¯è¬åããã£ã¦ããã®å¹ç¨ã¨å
¥æãããããã¨ããä¸è¬çãªè¬å¤ã§ããåãå¹ãç®ã®2ã¤ã§ããã大ããªéããããã¾ãã
ãããã½ãã³ï¼ããã½ãããã§ã³ãããªã¦ã ï¼ãã¯éã¹ããã¤ãæ§æççè¬ï¼NSAIDsï¼ã¨è¨ããã¾ãããæççãã¨ããããã«ãççãçºç±ãçã¿ãªã©ãèµ·ããä½å
ç©è³ªãããã¹ã¿ã°ã©ã³ã¸ã³ãã®çæãæããä½ç¨ãããã¾ãã注æç¹ã¯ãèè
¸ã¸ã®å¯ä½ç¨ããããã¨ã§ãã空è
¹æã®æç¨ã¯é¿ãã¾ããããã¾ãæ¶åæ½°çããããèè
¸ãå¼±ãå ´åã¯ãåãæ°ãååæãè
¹çãªã©ãä¼´ããªã¹ã¯ãããã¾ãã
ãã«ããã¼ã«ï¼ã¢ã»ãã¢ãããã§ã³ï¼ãã¯ãéããªã³ç³»è§£ç±é®çè¬ã¨è¨ãããè³å
ã®ä¸æ¢ç¥çµã«ä½ç¨ãã解ç±é®çå¹æãçºæ®ãã¾ããæççä½ç¨ã¯ããã¾ããããããã½ãã³ã¨æ¯è¼ãã¦ç©ãããªå¹ãç®ããå¦å©¦ãå°å
ã¸ç¨ãããã¾ããå¯ä½ç¨ã¨ãã¦ã¯ãçºç¹ãååãªã©ãå ±åããã¦ãã¾ãã
ãããã½ãã³ãã¯ãæè¡å¾ãå¤å·ãªã©ã®ççãä¼´ãçã¿ãæããè¬å¤ã¨ãã¦ãå»çæ©é¢ã§ã¯ä½¿ç¨ããã¦ãã¾ãããã ãå°å
ç¨ã«ã¯ä½¿ç¨ããããã¾ãåã©ãã®ããã®ç¨éè¨å®ãããã¦ãã¾ããããã®å ´åã¯ãå°å
ãåã©ãã¸ã®ç¨éè¨å®ããããã«ããã¼ã«ããå¦æ¹ããã¾ãã
ãã®ããã«ãããã½ãã³ãã¨ãã«ããã¼ã«ãã«ã¯ã大ããªéããããã¾ããç¹ã«15æ³æªæºã®åã©ããå¦å©¦ãã¾ãèè
¸ã®ç¶æ
ã«ã¯æ³¨æãå¿
è¦ã§ããéã¹ããã¤ãæ§æççè¬ï¼NSAIDsï¼ã«ã¯ãããã«ã¿ã¬ã³ããã¤ããããã§ã³ããã¢ã¹ããªã³ããªã©ã®è§£ç±é®çå¤ãããã¾ããããæç¨ã®éã«ã¯ãå»å¸«ãè¬å¤å¸«ã¸ç¸è«ããã¾ãããã
ããã½ãã³ãã«ããã¼ã«ã®éã
ããã½ãã³ã¨ã¯
ã»ä¸è¬åï¼ããã½ãããã§ã³ãããªã¦ã
ã»éã¹ããã¤ãæ§æççè¬ï¼NSAIDsï¼ã®ã¿ã¤ã
ã»ä½å
ã®ãçã¿ãççãçºç±ããªã©ãå¼ãèµ·ããç©è³ªï¼ããã¹ã¿ã°ã©ã³ã¸ã³ï¼ãä½ãããã®ãæãããã¨ã«ãã£ã¦ãççã«ä¼´ãè
«ããçã¿ããããããç±ãä¸ãã¾ã
ã»å¯ä½ç¨ï¼èè
¸é害ãé£æ¬²ä¸æ¯ãèããããè
¹çãªã©
ã»èè
¸ãå¼±ãæ¹ãæ¶åæ½°çã®æ¹ã¯ãæç¨ã«ã¯æ³¨æãå¿
è¦ã§ã
ã»å¤åï¼é å¤ããã¼ããç²ãã²ã«ãªã©
ã«ããã¼ã«ã¨ã¯
ã»ä¸è¬åï¼ã¢ã»ãã¢ãããã§ã³
ã»éã¹ããã¤ãæ§æççè¬ï¼NSAIDSï¼ã§ã¯ãªã
ã»ã¢ã»ãã¢ãããã§ã³ã«ã¯ãé®çã»è§£ç±ä½ç¨ã¯ãããã®ã®ãæççä½ç¨ã¯ã»ã¨ãã©ããã¾ãã
ã»ããã½ãã³ãããç©ããã«å¹ããå°å
ãå¦å©¦ã«ã使ç¨ã§ãã¾ã
ã»å¤åï¼åå¤ãç²ãé å¤ãã·ããããªã©
éã¹ããã¤ãæ§æççè¬ã¯ãåã©ããå¦å©¦ã¯é£²ãã§ããã®ï¼
éã¹ããã¤ãæ§æççè¬ï¼NSAIDsï¼ã¨ã¯
ã»çã¿ããããããããççãæããããã«ä½¿ãããè¬ç©ã®ç·ç§°ã®ãã¨ã§ã
ã»ä»£è¡¨çãªãã®ã«ããã½ãã³ããã«ã¿ã¬ã³ãã¤ããããã§ã³ãã¢ã¹ããªã³ãªã©ãããã¾ã
ã»èç²æ¶²ãå°ãªããªã£ã¦ãã¾ããã¨ãããããã空è
¹æã®æç¨ã¯ã§ãã¾ãã
å¦å¨ ä¸ãåã©ãã®å ´åãåºæ¬çã«ã¯ã«ããã¼ã«ã®ä½¿ç¨ããããããã¾ã
â»è§£ç±é®çå¤ã使ãéã«ã¯å¦å©¦æ¤è¨ºã»å°å
ç§ã¸ç¸è«ãã
ã©ããªæã«ããã½ãã³ï¼ã«ããã¼ã«ï¼ 2ã¤ã®ä½¿ãåã
ããã½ãã³ã¯ççãä¼´ãçã¿ã«å¯¾ãã¦å¹æãããã¾ã
ãã®ãããæè¡å¾ãå¤å·ãªã©ççãä¼´ãçã¿ãªã©ã«å¯¾ãã¦ä½¿ç¨ããããã¨ãå¤ãã§ã
â解説è
ä¸ç°åæ
æ ªå¼ä¼ç¤¾Smart119 代表åç· å½¹
åè大å¦å¤§å¦é¢å»å¦ç ç©¶é¢ ææ¥éä¸æ²»çå»å¦ ææ
https://twitter.com/Nakada119
âç£ä¿®åå
æ°äºä¹
ç¾åï¼ææ¥ç§å°éå»ï¼
ç¢æ¾¤ã¾ãï¼å¤ç§å°éå»ï¼
âå°å·ç¨è³æãã¦ã³ãã¼ããªã³ã¯
https://smart119.biz/manga/000597.html
âåèè³æ
ã»ä¸è¬ç¤¾å£æ³äººæ¥æ¬ãã¤ã³ã¯ãªããã¯å¦ä¼
https://www.jspc.gr.jp/igakusei/igakusei_keynsaids.html
ã»ããç¼çã®è¬ç©çæ³ã«é¢ããã¬ã¤ãã©ã¤ã³ã2014å¹´ç
https://www.jspm.ne.jp/guidelines/pain/2014/pdf/pain2014.pdf
ï¼Antonucci R, Zaffanello M, Puxeddu E, Porcella A, Cuzzolin L, Pilloni MD, Fanos V. Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab. 2012 May 1;13ï¼4ï¼:474-90. doi: 10.2174/138920012800166607. PMID: 22299823.ï¼
âå»çæ
å ±ã¤ã©ã¹ãã¬ã¼ã·ã§ã³ã»ã·ãªã¼ãº ãã¼ã ãã¼ã¸
https://smart119.biz/manga/
Smart119
https://smart119.biz/
ï¼ãã¤ããåè²ã¦ç·¨éé¨ï¼